MarketPeel
Insider Trading Intelligence
Pricing
…
LP

Leonard E. Post

CGON
DIRECTOR · CG ONCOLOGY, INC. · CIK 0001235862
FILING MIX · LIFETIME47%/53%
BUYS
35
SELLS
39
TOTAL VALUE
$1.52M
COMPANIES
3
ACTIVE SINCE
Sep 2020
HOLDINGS NOW
149,571
AVG SELL PX
$38.71
TRADE KIND
SHOWING 74 / 74
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
18 backtested trades · 8 horizons · 20 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Leonard E. Post, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d18+61.11%-4.84%+0.29%-5.13%-3.42%—
14d18+61.11%-4.62%-0.02%-4.59%-3.71%—
30d18+61.11%-0.18%+1.02%-1.19%-5.60%—
60d18+61.11%+1.09%+1.59%-0.50%-6.00%—
90d18+66.67%-1.29%+2.06%-3.36%-7.22%—
180d18+38.89%+34.06%+6.29%+27.77%+28.22%—
1y18(6 pending)+16.67%+63.35%+17.09%+46.27%+47.39%—
2y18(14 pending)+75.00%+73.23%+37.61%+35.62%-71.47%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CGON · 106,077 shares · as of Jun 24, 2026
033,51967,039100,558134,07720252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 35 buys / 39 sellsCOVERAGE · 24 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CGON
CG ONCOLOGY, INC.
SALE10b5-1
10b5-1 plan
5,000$70.00$350.0K0Jun 24, 2026Jun 25, 2026 ↗View →
CGON
CG ONCOLOGY, INC.
SALE
5,000——106,077Jun 24, 2026Jun 25, 2026 ↗View →
CGON
CG ONCOLOGY, INC.
PURCHASE
5,000$0.60$3.0K5,000Jun 24, 2026Jun 25, 2026 ↗View →
CGON
CG ONCOLOGY, INC.
SALE
5,000——111,077Jun 22, 2026Jun 23, 2026 ↗View →
CGON
CG ONCOLOGY, INC.
SALE10b5-1
10b5-1 plan
5,000$65.00$325.0K0Jun 22, 2026Jun 23, 2026 ↗View →
CGON
CG ONCOLOGY, INC.
PURCHASE
5,000$0.60$3.0K5,000Jun 22, 2026Jun 23, 2026 ↗View →
QURE
UNIQURE N.V.
SALE
1,993$27.06$53.9K35,494Jun 11, 2026Jun 12, 2026 ↗View →
QURE
UNIQURE N.V.
PURCHASEGRANT
Stock grant
13,980——13,980Jun 10, 2026Jun 12, 2026 ↗View →
QURE
UNIQURE N.V.
PURCHASEGRANT
Stock grant
7,550——37,487Jun 10, 2026Jun 12, 2026 ↗View →
CGON
CG ONCOLOGY, INC.
PURCHASE
1,000$0.60$6001,000Jun 4, 2026Jun 5, 2026 ↗View →
CGON
CG ONCOLOGY, INC.
SALE10b5-1
10b5-1 plan
1,000$54.50$54.5K0Jun 4, 2026Jun 5, 2026 ↗View →
CGON
CG ONCOLOGY, INC.
SALE
1,000——116,077Jun 4, 2026Jun 5, 2026 ↗View →
CGON
CG ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
9,354——9,354Jun 4, 2026Jun 5, 2026 ↗View →
CGON
CG ONCOLOGY, INC.
PURCHASE
1,000$0.60$6001,000Nov 17, 2025Nov 18, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
SALE
1,000——117,077Nov 17, 2025Nov 18, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
SALE10b5-1
10b5-1 plan
1,000$41.43$41.4K0Nov 17, 2025Nov 18, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
SALE
1,000——118,077Oct 13, 2025Oct 15, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
SALE10b5-1
10b5-1 plan
1,000$43.25$43.3K0Oct 13, 2025Oct 15, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
PURCHASE
1,000$0.60$6001,000Oct 13, 2025Oct 15, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
SALE
5,000——119,077Sep 30, 2025Oct 1, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
SALE10b5-1
10b5-1 plan
5,000$40.09$200.4K0Sep 30, 2025Oct 1, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
PURCHASE
5,000$0.60$3.0K5,000Sep 30, 2025Oct 1, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
SALE
1,000——124,077Sep 15, 2025Sep 16, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
PURCHASE
1,000$0.60$6001,000Sep 15, 2025Sep 16, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
SALE10b5-1
10b5-1 plan
1,000$35.10$35.1K0Sep 15, 2025Sep 16, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
SALE10b5-1
10b5-1 plan
1,000$28.00$28.0K0Sep 3, 2025Sep 4, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
PURCHASE
1,000$0.60$6001,000Sep 3, 2025Sep 4, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
SALE
1,000——125,077Sep 3, 2025Sep 4, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
SALE10b5-1
10b5-1 plan
2,000$28.00$56.0K0Jul 17, 2025Jul 18, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
PURCHASE
2,000$0.60$1.2K2,000Jul 17, 2025Jul 18, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
SALE
2,000——126,077Jul 17, 2025Jul 18, 2025 ↗View →
QURE
UNIQURE N.V.
SALE
2,112$14.45$30.5K29,937Jun 20, 2025Jun 24, 2025 ↗View →
QURE
UNIQURE N.V.
PURCHASEGRANT
Stock grant
15,630——15,630Jun 11, 2025Jun 13, 2025 ↗View →
QURE
UNIQURE N.V.
PURCHASEGRANT
Stock grant
7,970——32,049Jun 11, 2025Jun 13, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
24,165——24,165Jun 5, 2025Jun 5, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
SALE10b5-1
10b5-1 plan
1,000$28.00$28.0K0May 21, 2025May 22, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
SALE
1,000——128,077May 21, 2025May 22, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
PURCHASE
1,000$0.60$6001,000May 21, 2025May 22, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
PURCHASE
1,000$0.60$6001,000Apr 28, 2025Apr 29, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
SALE10b5-1
10b5-1 plan
1,000$30.76$30.8K0Apr 28, 2025Apr 29, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
SALE
1,000——129,077Apr 28, 2025Apr 29, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
SALE
1,000——130,077Mar 17, 2025Mar 18, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
PURCHASE
1,000$0.60$6001,000Mar 17, 2025Mar 18, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
SALE10b5-1
10b5-1 plan
1,000$28.00$28.0K0Mar 17, 2025Mar 18, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
PURCHASE
1,000$0.60$6001,000Feb 18, 2025Feb 19, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
SALE10b5-1
10b5-1 plan
1,000$28.61$28.6K0Feb 18, 2025Feb 19, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
SALE
1,000——131,077Feb 18, 2025Feb 19, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
SALE10b5-1
10b5-1 plan
1,000$29.66$29.7K0Jan 13, 2025Jan 14, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
SALE
1,000——132,077Jan 13, 2025Jan 14, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
PURCHASE
1,000$0.60$6001,000Jan 13, 2025Jan 14, 2025 ↗View →
CGON
CG ONCOLOGY, INC.
SALE
1,000——133,077Dec 16, 2024Dec 17, 2024 ↗View →
CGON
CG ONCOLOGY, INC.
SALE10b5-1
10b5-1 plan
1,000$28.84$28.8K0Dec 16, 2024Dec 17, 2024 ↗View →
CGON
CG ONCOLOGY, INC.
PURCHASE
1,000$0.60$6001,000Dec 16, 2024Dec 17, 2024 ↗View →
CGON
CG ONCOLOGY, INC.
SALE
1,000——134,077Dec 6, 2024Dec 6, 2024 ↗View →
CGON
CG ONCOLOGY, INC.
PURCHASE
1,000$0.60$6001,000Dec 6, 2024Dec 6, 2024 ↗View →
CGON
CG ONCOLOGY, INC.
SALE10b5-1
10b5-1 plan
750$34.40$25.8K250Dec 6, 2024Dec 6, 2024 ↗View →
CGON
CG ONCOLOGY, INC.
SALE10b5-1
10b5-1 plan
250$34.98$8.7K0Dec 6, 2024Dec 6, 2024 ↗View →
CGON
CG ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
15,600——15,600Oct 4, 2024Oct 7, 2024 ↗View →
QURE
UNIQURE N.V.
PURCHASEGRANT
Stock grant
8,080——24,079Jun 19, 2024Jun 21, 2024 ↗View →
QURE
UNIQURE N.V.
PURCHASEGRANT
Stock grant
15,840——15,840Jun 19, 2024Jun 21, 2024 ↗View →
QURE
UNIQURE N.V.
SALE
2,222$5.14$11.4K15,999Jun 13, 2024Jun 18, 2024 ↗View →
QURE
UNIQURE N.V.
SALE
2,291$18.83$43.1K18,221Jun 16, 2023Jun 20, 2023 ↗View →
QURE
UNIQURE N.V.
PURCHASEGRANT
Stock grant
8,700——20,512Jun 13, 2023Jun 20, 2023 ↗View →
QURE
UNIQURE N.V.
PURCHASEGRANT
Stock grant
17,060——17,060Jun 13, 2023Jun 20, 2023 ↗View →
QURE
UNIQURE N.V.
SALE
389$19.73$7.7K11,812Feb 27, 2023Mar 1, 2023 ↗View →
FLGT
FULGENT GENETICS, INC.
PURCHASEGRANT
Stock grant
8,000——8,000Aug 1, 2022Aug 3, 2022 ↗View →
QURE
UNIQURE N.V.
PURCHASEGRANT
Stock grant
9,080——12,201Jun 15, 2022Jun 17, 2022 ↗View →
QURE
UNIQURE N.V.
PURCHASEGRANT
Stock grant
17,810——17,810Jun 15, 2022Jun 17, 2022 ↗View →
QURE
UNIQURE N.V.
SALE
795$16.64$13.2K3,121Feb 28, 2022Mar 2, 2022 ↗View →
QURE
UNIQURE N.V.
PURCHASEGRANT
Stock grant
1,534——3,916Feb 24, 2022Feb 28, 2022 ↗View →
QURE
UNIQURE N.V.
PURCHASEGRANT
Stock grant
2,645——2,645Feb 24, 2022Feb 28, 2022 ↗View →
QURE
UNIQURE N.V.
PURCHASEGRANT
Stock grant
4,107——4,107Feb 25, 2021Mar 1, 2021 ↗View →
QURE
UNIQURE N.V.
PURCHASEGRANT
Stock grant
2,382——2,382Feb 25, 2021Mar 1, 2021 ↗View →
QURE
UNIQURE N.V.
PURCHASEGRANT
Stock grant
10,000——10,000Sep 15, 2020Sep 17, 2020 ↗View →
Other insiders · CGON
Loading peer insiders…
About this filer
CIK 0001235862
ROLE
Director
PRIMARY
CGON
COMPANIES
3
ACTIVE SINCE
Sep 2020
MARKETPEEL · /INSIDER/0001235862DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback